SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-21-009319
Filing Date
2021-02-16
Accepted
2021-02-16 10:03:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13G ea135432-13ga5ubs_protalix.htm SC 13G/A 29693
  Complete submission text file 0001213900-21-009319.txt   31412
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 21633765
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE NORTH WACKER DRIVE 31ST FLOOR CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE 31ST FLOOR CHICAGO IL 60606 3125256000
UBS OCONNOR LLC (Filed by) CIK: 0001132716 (see all company filings)

IRS No.: 061569842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A